Corn and Avocado Oils for High Cholesterol
This study is looking at how corn oil and avocado oil affect cholesterol levels in people with mild to moderately high non-HDL-C (a type of 'bad' cholesterol). You might be able to join if you are between 18 and 74 years old and have non-HDL-C levels between 125 and 225 mg/dL. The study aims to see if these oils can help improve your cardiometabolic risk factor profile. The study's status is currently unclear, and it plans to enroll 54 participants.
- Study design
- This is an interventional study, meaning participants will receive specific interventions (corn oil or avocado oil). It plans to enroll 54 participants.
- What's involved
- You would consume a controlled diet with either corn oil or avocado oil for two separate 21-day periods, with a 21-day break in between. You would also need to attend 7 clinic visits.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your non-HDL-C will be measured from the start of the study (day 0) to the end of each 21-day diet period.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
NCT07514663
Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile
Recruiting
NAAges 18–74InterventionalMidwest Center for Metabolic and Cardiovascular ResearchInvestigator-initiated
~54 participants
Updated 2026-04-17 on ClinicalTrials.gov
What's tested:corn oilAvocado Oil
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Non-high density lipoprotein cholesterol (non-HDL-C)
Measured over Baseline (day 0) to end of each condition (day 21)
Conditions
Where it's being run
1 sites across 1 statesIllinois1
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Non-high density lipoprotein cholesterol (non-HDL-C)Baseline (day 0) to end of each condition (day 21)
Percentage change in non-HDL-C concentration